1. Home
  2. ACOG vs LSE Comparison

ACOG vs LSE Comparison

Compare ACOG & LSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACOG
  • LSE
  • Stock Information
  • Founded
  • ACOG 2000
  • LSE 2007
  • Country
  • ACOG Canada
  • LSE China
  • Employees
  • ACOG N/A
  • LSE N/A
  • Industry
  • ACOG
  • LSE Metal Fabrications
  • Sector
  • ACOG
  • LSE Industrials
  • Exchange
  • ACOG Nasdaq
  • LSE Nasdaq
  • Market Cap
  • ACOG 80.3M
  • LSE 95.5M
  • IPO Year
  • ACOG N/A
  • LSE 2024
  • Fundamental
  • Price
  • ACOG $9.74
  • LSE $5.44
  • Analyst Decision
  • ACOG Strong Buy
  • LSE
  • Analyst Count
  • ACOG 1
  • LSE 0
  • Target Price
  • ACOG $20.00
  • LSE N/A
  • AVG Volume (30 Days)
  • ACOG 196.9K
  • LSE 8.2K
  • Earning Date
  • ACOG 05-15-2025
  • LSE 01-01-0001
  • Dividend Yield
  • ACOG N/A
  • LSE N/A
  • EPS Growth
  • ACOG N/A
  • LSE N/A
  • EPS
  • ACOG N/A
  • LSE 0.52
  • Revenue
  • ACOG $2,928,654.00
  • LSE $69,073,374.00
  • Revenue This Year
  • ACOG N/A
  • LSE N/A
  • Revenue Next Year
  • ACOG N/A
  • LSE N/A
  • P/E Ratio
  • ACOG N/A
  • LSE $10.24
  • Revenue Growth
  • ACOG N/A
  • LSE N/A
  • 52 Week Low
  • ACOG $3.75
  • LSE $3.76
  • 52 Week High
  • ACOG $11.40
  • LSE $14.99
  • Technical
  • Relative Strength Index (RSI)
  • ACOG N/A
  • LSE N/A
  • Support Level
  • ACOG N/A
  • LSE N/A
  • Resistance Level
  • ACOG N/A
  • LSE N/A
  • Average True Range (ATR)
  • ACOG 0.00
  • LSE 0.00
  • MACD
  • ACOG 0.00
  • LSE 0.00
  • Stochastic Oscillator
  • ACOG 0.00
  • LSE 0.00

About ACOG Alpha Cognition Inc. Common Stock

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

About LSE Leishen Energy Holding Co. Ltd. Ordinary Shares

Leishen Energy Holding Co Ltd is a provider of clean-energy equipment and integrated solutions to the oil and gas industry, with a commitment to providing customers with high-performance, safe, and cost-effective energy solutions. The company's business segments include clean-energy equipment; oil and gas engineering technical services; new energy production and operation; and digitalization and integration equipment. A majority of its revenue is generated from the clean-energy equipment segment which supplies various equipments, such as reciprocating compressor units, expansion units, wellhead heating systems, wellhead safety control systems, oil-water separation systems, natural gas online sampling systems, oil and gas skid-mounted equipment, and polymer flexible composite pipes.

Share on Social Networks: